Actinium Pharmaceuticals, Inc. (ATNM)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch ATNM
See up to 3 months of ATNM. The 7-day demo opens the 1M and 3M ranges and puts ATNM on your watchlist.
Start 7-day demoLatest ATNM insider trades
About Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals, Inc. files with the SEC under CIK 0001388320 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
ATNM Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 13 | 3,578,274 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ATNM insider transactions (Form 4)
239 Form 4 filings on record, the earliest from Nov 5, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ajit Shetty - Director | Grant or award | Common Stock | 61,600 footnote F1 | $0.00 | - | |
| Ajit Shetty - Director | Grant or award | Stock Option (Right to Buy) | 92,400 | $0.00 | - | |
| ||||||
| C. David Nicholson, - Director | Grant or award | Common Stock | 62,800 footnote F1 | $0.00 | - | |
| C. David Nicholson, - Director | Grant or award | Stock Option (Right to Buy) | 94,200 | $0.00 | - | |
| ||||||
 June Sherie Almenoff - Director | Grant or award | Common Stock | 18,000 footnote F1 | $0.00 | - | |
| June Sherie Almenoff - Director | Grant or award | Stock Option (Right to Buy) | 27,000 | $0.00 | - | |
| ||||||
 Sandesh Seth - Officer | Grant or award | Common Stock | 753,600 footnote F1 | $0.00 | - | |
| Sandesh Seth - Officer | Grant or award | Common Stock | 1,027,274 footnote F2 | $0.00 | - | |
| Sandesh Seth - Officer | Grant or award | Stock Option (Right to Buy) | 1,130,400 | $0.00 | - | |
| ||||||
 Richard I. Steinhart - Director | Grant or award | Common Stock | 62,800 footnote F1 | $0.00 | - | |
| Richard I. Steinhart - Director | Grant or award | Stock Option (Right to Buy) | 94,200 | $0.00 | - | |
| ||||||
| Jeffrey W. Chell - Director | Grant or award | Common Stock | 61,600 footnote F1 | $0.00 | - | |
| Jeffrey W. Chell - Director | Grant or award | Stock Option (Right to Buy) | 92,400 | $0.00 | - | |
| ||||||
| Sandesh Seth - Officer | Tax withholding / forfeiture | Common Stock | 120,900 | $1.71 | $207K | |
| Richard I. Steinhart - Director | Derivative | Stock Option (Right to Buy) | 2,500 | $0.00 | - | |
| Richard I. Steinhart - Director | Derivative | Stock Option (Right to Buy) | 2,500 | $0.00 | - | |
| Richard I. Steinhart - Director | Derivative | Stock Option (Right to Buy) | 2,500 | $0.00 | - | |
| Richard I. Steinhart - Director | Derivative | Stock Option (Right to Buy) | 8,333 | $0.00 | - | |
| Richard I. Steinhart - Director | Derivative | Stock Option (Right to Buy) | 8,333 | $0.00 | - | |
| Richard I. Steinhart - Director | Derivative | Stock Option (Right to Buy) | 18,351 | $0.00 | - | |
| Richard I. Steinhart - Director | Derivative | Stock Option (Right to Buy) | 72,156 | $0.00 | - | |
| Richard I. Steinhart - Director | Derivative | Stock Option (Right to Buy) | 70,311 | $0.00 | - | |
| June Sherie Almenoff - Director | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
Item 3.01, 7.01, 9.01
Item 8.01
Item 3.01, 7.01, 9.01
Item 5.07
ATNM insider trading FAQ
What is the latest insider trade for ATNM?
Actinium Pharmaceuticals, Inc. (ATNM) had 6 insider filings in the last 90 days, with the most recent on 2026-09-04. The full record for ATNM runs to 9 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ATNM stock?
No insider purchases of ATNM were filed in the last 90 days.
How many insiders are selling ATNM stock?
No insider sales of ATNM were filed in the last 90 days.
Where can I see ATNM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ATNM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
9The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ajit Shetty view on EDGAR
- - C. David Nicholson, view on EDGAR
- - June Sherie Almenoff view on EDGAR
- - Sandesh Seth view on EDGAR
- - Richard I. Steinhart view on EDGAR
- - Jeffrey W. Chell view on EDGAR
- - Sandesh Seth view on EDGAR
- - Richard I. Steinhart view on EDGAR
- - June Sherie Almenoff view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ATNM's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ATNM with a 7-day demo
- ATNM on your watchlist
- Every ATNM Form 4 filing on record
- Up to 3 months of ATNM price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
